Logo Lanfrica
  • Accueil
  • Atlas
  • Analyses
  • Documentation
  • Sign in

© 2026 Lanfrica. Tous droits réservés. Tous les droits d'auteur des ressources affichées sur le site Web Lanfrica appartiennent aux détenteurs de droits d'auteur d'origine, sauf indication contraire explicite.

Digital Transformation in Pharmaceutical Supply Chain: An African Case

Domaine:

healthcaredigital infrastructure

Type de record:

paper
Créateur:
Bankole Ibrahim AshiwajuMerCasOch
Éditeur:
Med
Hôte:
Abstract Background: The pharmaceutical supply chain, pivotal in ensuring timely and efficient delivery of medical goods, has experienced significant challenges in the African context. Infrastructure deficiencies, fragmented distribution networks, and limited transparency have historically been obstacles in ensuring the consistent flow of essential drugs and treatments. Materials and Methods: The transformative power of digital technologies in reconfiguring the pharmaceutical supply chain across Africa. Drawing on multiple case studies, this paper presents evidence of how technologies such as blockchain, artificial intelligence, and the Internet of Things (IoT) are being employed to enhance traceability, improve inventory management, and optimize distribution routes. These digital innovations are not only ensuring the integrity of medicines by reducing counterfeit products but are also enhancing the agility of the supply chain to respond to sudden market and health demands. Results: Executed in a thorough data analysis strategy to interpret the results and extract significant insights by investigating the challenges faced in this digital transformation, which include the need for skills development, infrastructure investment, and the creation of supportive regulatory environments. The study underscores the role of partnerships between governments, international organizations, and private enterprises in driving these innovations. Conclusion: While the journey of digital transformation in Africa’s pharmaceutical supply chain is ongoing, there are promising strides being made. By embracing digital solutions, Africa is positioning itself to better tackle health challenges and ensuring that its populace has access to genuine and essential medicines. This research contributes to a deeper understanding of digital transition strategies and offers actionable insights for stakeholders involved in global health and supply chain management.

Visit

doi.org

Similaires

Covid-19 and the South African pharmaceutical supply chainDigital Transformation and Supply Chain Agility in an Emerging Economy: Mediating Role of Dynamic CapabilitiesLEVERAGING DIGITAL TRANSFORMATION TO ENHANCE SUPPLY CHAIN RESILIENCE IN EMERGING ECONOMIESPharmaceutical Supply Chain Risk Assessment in the Time of COVID 19/Case StudyTowards a Constrained-Efficiency Framework for the Digital Transformation in Agri-food Supply Chains:A Case of the Tomato Supply Chain in NigeriaAn examination of pharmaceutical supply chain for artemisinin‐based combination therapies in Ghana

Covid-19 and the South African pharmaceutical supply chain

This research aimed to identify the key drivers of the pharmaceutical supply chain during the COVID-

Digital Transformation and Supply Chain Agility in an Emerging Economy: Mediating Role of Dynamic Capabilities

This study examined the influence of digital transf

LEVERAGING DIGITAL TRANSFORMATION TO ENHANCE SUPPLY CHAIN RESILIENCE IN EMERGING ECONOMIES

This paper explores the connection be

Pharmaceutical Supply Chain Risk Assessment in the Time of COVID 19/Case Study

International audience As of March11, 2020 the world Health Organization (WHO) declar

Towards a Constrained-Efficiency Framework for the Digital Transformation in Agri-food Supply Chains:A Case of the Tomato Supply Chain in Nigeria

This thesis interrogates the paradoxes of digital transformation in Nigeria's agri-food supply chain

An examination of pharmaceutical supply chain for artemisinin‐based combination therapies in Ghana

Purpose The purpose of this paper is to examine the pharmaceutical supply chain for artemisinin‐bas